Predictive markers of asymptomatic atherosclerosis in end-stage renal disease patients

REFERENCES

• Levey AS, Beto JA, Coronado BE, Controlling the epidemic of cardiovascular disease in chronic renal disease: What do we know? What do we need to learn? Where do we go from here? National kidney foundation task force on cardiovascular disease. Am J Kidney Dis. 1998;32(5):853–906.
   PubMed Web of Science ®Google Scholar
• Urso S, Garozzo M, Milone F, Battaglia G. Cardiovascular risk markers in hemodialysis patients. Int J Artif Organs. 2004;27(12):1083–1090.
   PubMedGoogle Scholar
• Iliou MC, Fumeron C, Benoit MO, Factors associated with increased serum levels of cardiac troponins T and I in chronic hemodialysis patients: Chronic hemodialysis and new cardiac markers evaluation (CHANCE) study. Nephrol Dial Transplant. 2001;16(7):1452–1458.
   PubMedGoogle Scholar
• Diris JH, Hackeng CM, Kooman JP, Pinto YM, Hermens WT, van Dieijen-Visser MP. Impaired renal clearance explains elevated troponin T fragments in hemodialysis patients. Circulation. 2004;109(1):23–25.
   PubMed Web of Science ®Google Scholar
• Sharma R, Gaze DC, Pellerin D, Cardiac structural and functional abnormalities in end stage renal disease patients with elevated cardiac troponin T. Heart. 2006;92(6):804–809.
   PubMed Web of Science ®Google Scholar
• Dierkes J, Domrose U, Westphal S, Cardiac troponin T predicts mortality in patients with end-stage renal disease. Circulation. 2000;102(16):1964–1969.
   PubMedGoogle Scholar
• Khan NA, Hemmelgarn BR, Tonelli M, Thompson CR, Levin A. Prognostic value of troponin T and I among asymptomatic patients with end-stage renal disease: A meta-analysis. Circulation. 2005;112(20):3088–3096.
   PubMed Web of Science ®Google Scholar
• Mallamaci F, Zoccali C, Parlongo S, Diagnostic value of troponin T for alterations in left ventricular mass and function in dialysis patients. Kidney Int. 2002;62(5):1884–1890.
   PubMedGoogle Scholar
• Abaci A, Ekici E, Oguzhan A, Tokgoz B, Utas C. Cardiac troponins T and I in patients with end-stage renal disease: The relation with left ventricular mass and their prognostic value. Clin Cardiol. 2004;27(12):704–709.
   PubMed Web of Science ®Google Scholar
• Apple FS, Murakami MM, Pearce LA, Herzog CA. Predictive value of cardiac troponin I and T for subsequent death in end-stage renal disease. Circulation. 2002;106(23):2941–2945.
   PubMed Web of Science ®Google Scholar
• Hickman PE, McGill DA, Talaulikar G, Prognostic efficacy of cardiac biomarkers for mortality in dialysis patients. Intern Med J. November 11, 2008 [Epub ahead of print].
   Google Scholar
• Ross R. Atherosclerosis–an inflammatory disease. N Engl J Med. 1999;340(2):115–126.
   PubMed Web of Science ®Google Scholar
• van der Sande FM, Kooman JP, Leunissen KM. The predictive value of C-reactive protein in end-stage renal disease: Is it clinically significant? Blood Purif. 2006;24(4):335–341.
   PubMed Web of Science ®Google Scholar
• Rao M, Jaber BL, Balakrishnan VS. Inflammatory biomarkers and cardiovascular risk: Association or cause and effect? Semin Dial. 2006;19(2):129–135.
   PubMedGoogle Scholar
• Racki S, Zaputovic L, Mavric Z, Vujicic B, Dvornik S. C-reactive protein is a strong predictor of mortality in hemodialysis patients. Ren Fail. 2006;28(5):427–433.
   PubMed Web of Science ®Google Scholar
• Zoccali C, Benedetto FA, Mallamaci F, Inflammation is associated with carotid atherosclerosis in dialysis patients. Creed investigators. Cardiovascular risk extended evaluation in dialysis patients. J Hypertens. 2000;18(9):1207–1213.
   PubMedGoogle Scholar
• Khosla UM, Zharikov S, Finch JL, Hyperuricemia induces endothelial dysfunction. Kidney Int. 2005;67(5):1739–1742.
   PubMed Web of Science ®Google Scholar
• Kang DH, Park SK, Lee IK, Johnson RJ. Uric acid-induced C-reactive protein expression: Implication on cell proliferation and nitric oxide production of human vascular cells. J Am Soc Nephrol. 2005;16(12):3553–3562.
   PubMed Web of Science ®Google Scholar
• Fang J, Alderman MH. Serum uric acid and cardiovascular mortality the NHANES I epidemiologic follow-up study, 1971–1992. National health and nutrition examination survey. JAMA. 2000;283(18):2404–2410.
   PubMed Web of Science ®Google Scholar
• Liese AD, Hense HW, Lowel H, Doring A, Tietze M, Keil U. Association of serum uric acid with all-cause and cardiovascular disease mortality and incident myocardial infarction in the MONICA Augsburg cohort. World Health Organization monitoring trends and determinants in cardiovascular diseases. Epidemiology. 1999;10(4):391–397.
   PubMedGoogle Scholar
• Hurst RT, Ng DW, Kendall C, Khandheria B. Clinical use of carotid intima-media thickness: Review of the literature. J Am Soc Echocardiogr. 2007;20(7):907–914.
   PubMed Web of Science ®Google Scholar
• Fabris F, Zanocchi M, Bo M, Carotid plaque, aging, and risk factors. A study of 457 subjects. Stroke. 1994;25(6): 1133–1140.
   PubMed Web of Science ®Google Scholar
• Zoungas S, Ristevski S, Lightfoot P, Carotid artery intima-medial thickness is increased in chronic renal failure. Clin Exp Pharmacol Physiol. 2000;27(8):639–641.
   PubMed Web of Science ®Google Scholar
• Nishizawa Y, Shoji T, Maekawa K, Intima-media thickness of carotid artery predicts cardiovascular mortality in hemodialysis patients. Am J Kidney Dis. 2003;41(3 Suppl. 1):S76–S79.
   PubMed Web of Science ®Google Scholar
• Homma S, Hirose N, Ishida H, Ishii T, Araki G. Carotid plaque and intima-media thickness assessed by b-mode ultrasonography in subjects ranging from young adults to centenarians. Stroke. 2001;32(4):830–835.
   PubMedGoogle Scholar
• Altekin ER, Demir I, Basarici I, Yilmaz H. The relationship between carotid intima-media thickness and the presence and extent of angiographic coronary artery disease. Türk Kardiyol Dern Ars. 2007;35(2): 90–96.
   Google Scholar
• Hart PM, Feinfeld DA, Briscoe AM, Nurse HM, Hotchkiss JL, Thomson GE. The effect of renal failure and hemodialysis on serum and urine myoglobin. Clin Nephrol. 1982;18(3):141–143.
   PubMedGoogle Scholar
• Ma KW, Brown DC, Steele BW, From AH. Serum creatine kinase MB isoenzyme activity in long-term hemodialysis patients. Arch Intern Med. 1981;141(2):164–166.
   PubMedGoogle Scholar
• Robbins MJ, Epstein EM, Shah S. Creatine kinase subform analysis in hemodialysis patients without acute coronary syndromes. Nephron. 1997;76(3):296–299.
   PubMedGoogle Scholar
• Martin GS, Becker BN, Schulman G. Cardiac troponin-I accurately predicts myocardial injury in renal failure. Nephrol Dial Transplant. 1998;13(7):1709–1712.
   PubMed Web of Science ®Google Scholar
• Apple FS, Sharkey SW, Hoeft P, Prognostic value of serum cardiac troponin I and T in chronic dialysis patients: A 1-year outcomes analysis. Am J Kidney Dis. 1997;29(3): 399–403.
   PubMedGoogle Scholar
• Antman EM. Decision making with cardiac troponin tests. N Engl J Med. 2002;346(26):2079–2082.
   PubMedGoogle Scholar
• Mallamaci F, Zoccali C, Parlongo S, Troponin is related to left ventricular mass and predicts all-cause and cardiovascular mortality in hemodialysis patients. Am J Kidney Dis. 2002; 40(1):68–75.
   PubMedGoogle Scholar
• Fehr T, Knoflach A, Ammann P, Pei P, Binswanger U. Differential use of cardiac troponin T versus I in hemodialysis patients. Clin Nephrol. 2003;59(1):35–39.
   PubMedGoogle Scholar
• McLaurin MD, Apple FS, Voss EM, Herzog CA, Sharkey SW. Cardiac troponin I, cardiac troponin T, and creatine kinase MB in dialysis patients without ischemic heart disease: Evidence of cardiac troponin T expression in skeletal muscle. Clin Chem. 1997;43(6 Pt. 1):976–982.
   PubMed Web of Science ®Google Scholar
• Bodor GS, Porterfield D, Voss EM, Smith S, Apple FS. Cardiac troponin-I is not expressed in fetal and healthy or diseased adult human skeletal muscle tissue. Clin Chem. 1995;41(12 Pt. 1): 1710–1715.
   PubMedGoogle Scholar
• Wayand D, Baum H, Schatzle G, Scharf J, Neumeier D. Cardiac troponin T and I in end-stage renal failure. Clin Chem. 2000;46(9):1345–1350.
   PubMed Web of Science ®Google Scholar
• Tarakcioglu M, Erbagci AB, Usalan C, Deveci R, Kocabas R. Acute effect of hemodialysis on serum levels of the proinflammatory cytokines. Mediators Inflamm. 2003;12(1):15–19.
   PubMed Web of Science ®Google Scholar
• Beciani M, Tedesco A, Violante A, Cardiac troponin I (2nd generation assay) in chronic hemodialysis patients: Prevalence and prognostic value. Nephrol Dial Transplant. 2003;18(5):942–946.
   PubMedGoogle Scholar
• Stoffel MP, Pollok M, Baldamus CA. Troponin I is a better prognostic parameter of cardiovascular events in asymptomatic patients on hemodialysis than troponin T. Nephrol Dial Transplant. 2000;15(8):1259–1260.
   PubMedGoogle Scholar
• Farkouh ME, Robbins MJ, Urooj Zafar M, Association between troponin I levels and mortality in stable hemodialysis patients. Am J Med. 2003;114(3):224–226.
   PubMedGoogle Scholar
• Jung HH, Ma KR, Han H. Elevated concentrations of cardiac troponins are associated with severe coronary artery calcification in asymptomatic hemodialysis patients. Nephrol Dial Transplant. 2004;19(12):3117–3123.
   PubMedGoogle Scholar
• Hojs R, Ekart R, Hojs Fabjan T, Balon BP, Gorenjak M. Cardiac troponin T (cTnT) in hemodialysis patients with asymptomatic and symptomatic atherosclerosis. Arch Med Res. 2005;36(4):367–371.
   PubMedGoogle Scholar
• Zumrutdal A, Sezer S, Demircan S, Seydaoglu G, Ozdemir FN, Haberal M. Cardiac troponin I and beta 2 microglobulin as risk factors for early-onset atherosclerosis in patients on hemodialysis. Nephrology (Carlton). 2005;10(5):453–458.
   PubMedGoogle Scholar
• Stenvinkel P. Inflammation in end-stage renal disease: The hidden enemy. Nephrology (Carlton). 2006;11(1):36–41.
   PubMed Web of Science ®Google Scholar
• Lowbeer C, Stenvinkel P, Pecoits-Filho R, Elevated cardiac troponin T in predialysis patients is associated with inflammation and predicts mortality. J Intern Med. 2003;253(2):153–160.
   PubMedGoogle Scholar
• Boulier A, Jaussent I, Terrier N, Measurement of circulating troponin Ic enhances the prognostic value of C-reactive protein in hemodialysis patients. Nephrol Dial Transplant. 2004;19(9):2313–2318.
   PubMedGoogle Scholar
• Zumrutdal A, Demircan S, Seydaoglu G, Atherosclerosis in hemodialysis patients without significant comorbidities: Determinants of progression. Nephrology (Carlton). 2006;11(6):489–493.
   PubMedGoogle Scholar
• Reis KA, Guz G, Ozdemir H, Intravenous iron therapy as a possible risk factor for atherosclerosis in end-stage renal disease. Int Heart J. 2005;46(2):255–264.
   PubMedGoogle Scholar
• Tavil Y, Kaya MG, Oktar SO, Uric acid level and its association with carotid intima-media thickness in patients with hypertension. Atherosclerosis. 2008;197(1):159–163.
   PubMed Web of Science ®Google Scholar
• Montalcini T, Gorgone G, Gazzaruso C, Sesti G, Perticone F, Pujia A. Relation between serum uric acid and carotid intima-media thickness in healthy postmenopausal women. Intern Emerg Med. 2007;2(1):19–23.
   PubMedGoogle Scholar
• Kawamoto R, Tomita H, Oka Y, Kodama A, Ohtsuka N, Kamitani A. Association between uric acid and carotid atherosclerosis in elderly persons. Intern Med. 2005;44(8):787–793.
   PubMedGoogle Scholar
• Riccioni G, D’Orazio N, Palumbo N, Relationship between plasma antioxidant concentrations and carotid intima-media thickness: The asymptomatic carotid atherosclerotic disease in Manfredonia study. Eur J Cardiovasc Prev Rehabil. 2009;16(3):351–357.
   PubMedGoogle Scholar
• Beddhu S, Kaysen GA, Yan G, Association of serum albumin and atherosclerosis in chronic hemodialysis patients. Am J Kidney Dis. 2002;40(4):721–727.
   PubMedGoogle Scholar
• Foley RN, Parfrey PS, Harnett JD, Kent GM, Murray DC, Barre PE. Hypoalbuminemia, cardiac morbidity, and mortality in end-stage renal disease. J Am Soc Nephrol. 1996;7(5): 728–736.
   PubMed Web of Science ®Google Scholar
• Savage T, Clarke AL, Giles M, Tomson CR, Raine AE. Calcified plaque is common in the carotid and femoral arteries of dialysis patients without clinical vascular disease. Nephrol Dial Transplant. 1998;13(8):2004–2012.
   PubMedGoogle Scholar
• Oh DJ, Lee KJ. The relation between hypoalbuminemia and compliance and intima-media thickness of carotid artery in continuous ambulatory peritoneal dialysis patients. J Korean Med Sci. 2005;20(1):70–74.
   PubMed Web of Science ®Google Scholar
• Folsom AR, Ma J, Eckfeldt JH, Nieto FJ, Metcalf PA, Barnes RW. Low serum albumin. Association with diabetes mellitus and other cardiovascular risk factors but not with prevalent cardiovascular disease or carotid artery intima-media thickness. The atherosclerosis risk in communities (ARIC) study investigators. Ann Epidemiol. 1995;5(3):186–191.
   PubMedGoogle Scholar